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 2010 EMBO Molecular MedicineIt is widely thought that demyelination contributes to the degeneration of axons
and, in combination with acute inflammatory injury, is responsible for progress-
ive axonal loss and persistent clinical disability in inflammatory demyelinating
disease. In this study we sought to characterize the relationship between demye-
lination, inflammation and axonal transport changes using a Plp1-transgenic
mouse model of Pelizaeus-Merzbacher disease. In the optic pathway of this
non-immune mediated model of demyelination, myelin loss progresses from the
optic nerve head towards the brain, over a period of months. Axonal transport is
functionally perturbed at sites associated with local inflammation and ‘damaged’
myelin. Surprisingly, where demyelination is complete, naked axons appear well
preserved despite a significant reduction of axonal transport. Our results suggest
that neuroinflammation and/or oligodendrocyte dysfunction are more deleter-
ious for axonal health than demyelination per se, at least in the short term.INTRODUCTION
Multiple sclerosis (MS) is an inflammatory demyelinating
disorder in which the previously formed myelin sheath breaks
down. MS is considered the archetypal myelin disorder and
much current research focuses on the associated axonal loss; the
major cause of persistent disability (De Stefano et al, 1998;
Scolding & Franklin, 1998; Trapp &Nave, 2008). Axonal damage
in MS occurs in both the acute-inflammatory and late chronic
phases of the disease. The causes are not known, but
inflammation and loss of trophic support due to chronic
demyelination, respectively, could contribute (Bjartmar et al,
2003; Scolding & Franklin, 1998).parative Medicine,
entre, University of
ute of Experimental
ax: þ44-(0)141-330-Axonal transport impairment has been implicated in a
number of neurodegenerative disorders such as MS (Ferguson
et al, 1997) or spastic paraplegia type 2 (Edgar et al, 2004) in
which the primary defect is in the oligodendroglial proteolipid
protein (PLP1) gene. The aim of the present study was to
determine to what extent demyelination impairs axonal
transport and whether perturbed transport correlates with the
chronic absence of myelin or the acute inflammatory phase of
demyelination, or both. We selected as our model the optic
pathway of a Plp1-transgenic mouse (line #72) defined by about
twofold overexpression of PLP/DM20 (Anderson et al, 1999;
Readhead et al, 1994). In the optic nerve, active demyelination
with associated inflammation is succeeded by complete
demyelination in the absence of inflammation. For comparison,
we also examined the dysmyelinating Plp1-mutant rumpshaker
(Schneider et al, 1992). In rumpshaker, formation of the myelin
sheath is perturbed leading to a reduced amount of myelin, but
there is no evidence of demyelination and the inflammatory
response is moderate. Both the Plp1-transgenic mouse and
rumpshaker are models of Pelizaeus-Merzbacher disease
(PMD), an X-linked leukodystrophy most commonly caused
by duplication of the PLP1 gene (model: Plp1-transgenic
mouse), but also by point mutations (model: rumpshaker).EMBO Mol Med 2, 42–50 www.embomolmed.org
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transport impairment occurs at sites where active demyelination
is taking place and also at sites where axons remain ensheathed
by mutant oligodendrocytes. In contrast, axons in the
completely demyelinated region of the nerve appear structurally
and functionally preserved. These data suggest that inflamma-
tion and/or oligodendrocyte dysfunction in the Plp1-transgenic
mouse cause axonal pathology while complete demyelination
facilitates axonal survival under stress, at least in the short term.RESULTS
The optic pathway of Plp1-transgenic mice undergoes
temporo-spatially determined demyelination
The optic pathway of the Plp1-transgenic mouse exhibits
moderate dysmyelination followed by progressive demyelina-
tion that shows both temporal and spatial evolution. ByFigure 1. Demyelination progresses in a rostral to caudal direction with
increasing age in optic pathway of Plp1-transgenic mice.
A, B. The percentage of myelinated axons (A) and the relative volume of
myelin (B) at the chiasmal end of the optic nerve in wild type (WT) and
Plp1-transgenic (Tg) mice between P20 and P120.
C. Axon diameter frequency distribution at the chiasmal end of the optic
nerve of WT and Plp1-transgenic mice aged P120. Axonal diameter
distributions are not significantly different.
D, E. The percentage of myelinated axons (D) and the relative volume of
myelin (E) along the optic pathway of Plp1-transgenic mice at P40,
P60 and P120 showing the temporal and spatial progression of
demyelination.
www.embomolmed.org EMBO Mol Med 2, 42–50examining the mid point of the pathway, we showed that
myelination commenced on schedule and 44 and 60% of axons
were myelinated at P20 and P40, respectively; compared to
80 and 96% in the wild type (WT). However, demyelination led
to a complete absence of myelin by P120 (Fig 1A). These profiles
were mirrored by myelin volume (Mv) measurements (Fig 1B).
Myelin sheaths in the transgenic mice were of normal structure
and periodicity, but were thinner than in WT (g-ratio of
0.766 0.007 in mutant vs. 0.732 0.003 in controls at P60;
p< 0.05). Importantly, there was no significant reduction in
absolute axonal number at any age studied. At P120, axon
number in the Plp1-transgenic mice was 49,683 (964 SEM)
versus 48,768 (910 SEM) in WT, and axon diameter frequency
distributions were not different from WT (Fig 1C). P120 is the
oldest age examined, because the Plp1-transgenic mice rarely
live beyond this age.
To determine the spatial pattern of demyelination we
quantified the proportion of myelinated fibres and Mv at the
retinal and chiasmal ends of the optic nerve and at the mid optic
tract of transgenic mice. The data (Fig 1D, E) showed a distinct
pattern of demyelination progressing from the retinal end
towards the brain. At P30, the retinal end of the nerve had 40%
of axons myelinated (data not shown). At P120 the pathway
shows two distinct zones; a proximal (retinal) completely
demyelinated region and a distal actively demyelinating portion.
Electron microscopy of the proximal nerve revealed numerous
naked axons that appeared morphologically normal, with
interspersed astrocytic processes (Fig 2A and Supporting
Information Fig S1A). Microglia/macrophages were infrequent.
In contrast, the distal (chiasmal) end of the nerve, althoughFigure 2. Distribution of myelin and axonal pathology along the optic
pathway of Plp1-transgenic mice aged P120.
A. Retinal end of optic nerve: all myelin has been removed leaving naked
axons, which appear morphologically normal and are interspersed with
astrocyte processes. Bar: 1mm.
B, C. Chiasmal end of optic nerve: demyelination is on-going although most
axons have lost their sheaths. Microglia (M) and axonal spheroids (S) are
present. Bar: 2mm.
D. Optic tract: demyelination is present but not as advanced as at the
chiasm. Microglia and axonal spheroids are evident. Bar: 3mm.
 2010 EMBO Molecular Medicine 43
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44largely demyelinated, contained numerous active microglia/
macrophages (Fig 2B, C). The optic tract was similar, but
with a greater proportion of myelinated axons (Fig 2D and
Supporting Information Fig S1B). In both the chiasmal end of the
nerve and the tract, some axons showed disruption of the
cytoskeleton and/or accumulations of membranous organelles
(Fig 2B–D).
Electrical conduction in the dysmyelinated and demyelinated
optic nerve
To assess conduction in dysmyelinated and in demyelinated
nerves, stimulus-evoked compound action potentials (CAP)
were recorded from P40 and P120 WT and Plp1-transgenic
mice (Fig 3A, B). In WT mice, the CAP has a stereotypedFigure 3. Electrophysiological recordings from WT and Plp1-transgenic
optic nerves.
A. Representative recordings from P40 WT (____) and Plp1-transgenic (-----)
mice. In WT mice, the CAP has the stereotyped triple-peaked profile that
reflects populations of axons with different conduction velocities. The CAP
recorded from Plp1-transgenic mice resolved into three peaks, but the
duration of the CAP was longer than that of the control (6 ms vs. 3 ms)
signifying a decrease in the conduction velocity.
B. Representative recordings from P120 WT (____) and Plp1-transgenic (-----)
mice. The CAP recorded from P120 Plp1-transgenic mice was similar to
that of the P40 transgenic animals, but the peaks were less well
defined and their amplitudes were smaller. A total of 10 WT and 10
Plp1-transgenic nerves were examined.
 2010 EMBO Molecular Medicinetriple-peaked profile (Brown et al, 2003; Stys et al, 1998). In
transgenic mice the duration of the CAP was longer (6ms
in mutants vs. 3ms in controls) signifying a decrease
in conduction velocity, consistent with hypomyelination.
However, the CAP could still be resolved into three peaks.
The CAP recorded from P120 transgenic mice differed from P40
mice in that the amplitudes of the peaks were smaller. In the
absence of axonal loss (see above), reduced amplitudes were
most likely caused by conduction blocks along demyelinated
axons.
The inflammatory response is associated with active
demyelination
Since active demyelination is associated with inflammation (Ip
et al, 2006), we used the pan-leukocyte marker CD45 to identify
inflammatory cells in the Plp-transgenic mouse. Whereas in the
more distal portions of the P120 optic nerves the numbers of
CD45þ cells per optic nerve section were elevated >10-fold
comparedwithWT; the completely demyelinated retinal portion
showed no significant increase (Fig 4A). At P40, prior to overt
demyelination the cell numbers were strikingly lower than at
P120, although elevated compared withWT, probably reflecting
the underlying dysmyelination (Fig 4B). Direct correlation of
active demyelination and inflammation was achieved by
immunostaining for myelin basic protein (MBP) and CD45
(Fig 4C, E).
Using the T-cell marker CD3 we identified approximately
10–20 cells per 10mm thick longitudinal section (data not
shown). B-cells were rarely observed. We then focused on the
microglial/macrophage population using CD169 (sialoadhesin),
since CD169 expressing cells contribute to pathogenesis in
another Plp-transgenic line (line #66; Ip et al, 2006; Readhead et
al, 1994). Very few CD169þ cells were present in the
demyelinated retinal end of the P120 optic nerve, in contrast
to the abundant population at the chiasmal end (Fig 4C, D).
CD169þ cells were absent in WT (Fig 4C) and infrequent in P40
optic nerve, prior to overt demyelination (Fig 4E, F). In fact, the
pattern of expression of CD169 closely mirrored the progression
of active demyelination at all ages examined (Supporting
Information Fig S2). Note that in Fig 4E and Supporting
Information Fig S2, the variation in the intensity of MBP
staining probably reflects improved antibody penetration into
the demyelinating tissue.
Impaired retrograde axonal transport correlates with
active inflammation
The occurrence of axonal spheroids (Fig 2B–D) suggests
impaired axonal transport, as reported previously in the Plp1
gene knockout mouse (Edgar et al, 2004). To examine
retrograde transport, we injected fluorescein isothiocyanate
(FITC)-labelled cholera toxin B subunit (CtB) into the right
rostral colliculus of P40 or P120 mice and measured fluores-
cence signal in the contralateral retinal ganglion cells (RGC)
after 18 h. At P40 there was no significant difference in either
CtB-labelled area or mean signal intensity between transgenic
and WT mice (Fig 5A). At P120, mean signal intensity in RGCs
was significantly lower in transgenic mice than in WT, whereasEMBO Mol Med 2, 42–50 www.embomolmed.org
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Figure 4. Inflammatory cell numbers change in relation to chronic or
active demyelination.
A. CD45þ cell numbers along the optic pathway of WT and Plp1-transgenic
(Tg) mice aged P120. Whereas the demyelinated retinal region has no
increase in these cells there is a massive increase in the actively
demyelinating distal regions of the nerve.
B. At P40, prior to overt demyelination, the CD45þ cell numbers are similar
along the entire pathway. The increased number, relative to WT, reflects
the developmental dysmyelination.
C. Longitudinal sections of optic nerve from the retinal end (left) to the
chiasm from a Plp1-transgenic (Tg) mouse aged P120 immunostained for
MBP, CD45 and CD169, showing the gradient in myelin and macrophages
between the two ends of the optic nerve. Only CD169 is shown for the WT
mouse.
D. Enlarged images from the retinal and chiasmal ends of the optic nerve
from the Plp1-transgenic mouse illustrate the marked difference in the
densities of CD169þ cells between the two sites.
E. Longitudinal sections of optic nerve, as for C, from a Plp1-transgenic (#72)
aged P40. MBP immunoreactivity shows that the entire length of the nerve
(except the unmyelinated lamina cibrossa) is myelinated at this age.
Although CD45þ cells are present along the nerve, very few CD169þ cells
are evident.
F. Enlarged images from the retinal and chiasmal ends of the optic nerve
from the Plp1-transgenic (#72) mouse illustrating the scarcity of CD169þ
cells prior to overt demyelination. Bar¼50mm.the CtB-labelled area (an indication of the number of labelled
RGC) was similar (Fig 5A). Since axonal counts are not reduced
in themutants, this suggests that the average amount of material
transported along the length of an individual axon within 18 h is
reduced in the P120 mutant nerves. To visualize perturbations
of retrograde transport directly, we examined longitudinal
sections of the left optic nerve of Plp1-transgenic animals. At
P40, occasional focal accumulations of CtB in axons occurred
more often in the retinal portion of the nerve, where
demyelination is commencing, than in the chiasmal portion.
However, the difference between the two regions was not
significant (Fig 5B). Interestingly, at P120, numbers of focal
accumulations of tracer were significantly greater at the
inflamed chiasmal end of the nerve compared to the completely
demyelinated retinal end (Fig 5B, C).www.embomolmed.org EMBO Mol Med 2, 42–50Within axons, CtB accumulations often showed a punctate
appearance (Fig 5D), suggesting an association with endosomes
ormultivesicular bodies (MVBs). Electronmicroscopy following
3,3/5,5/-tetramethylbenzidine (TMB) labelling of peroxidase-
conjugated CtB showed that accumulations occurred at sites in
which axons appeared intact, and in some cases, myelinated
(Fig 5E, F).
Simultaneous injection of FITC-labelled CtB into the right
colliculus and tetramethyl rhodamine iso-thiocyanite (TRITC)-
labelled CtB into the left eye, led to the co-localization of the
tracers in some axonal swellings (Fig 5G–I and Supporting
Information Fig S3), demonstrating that these foci result from
the impairment of both anterograde and retrograde transport
and indicating that the associated axons are still intact.
Inflammation correlates with transport defects
The microglial/macrophage population in the transgenic
mouse optic nerve revealed a biphasic temporal course. There
was a low level of inherent microglia activation associated
with dysmyelination, followed by a massive activation in
areas of overt demyelination. To compare transport defects
in solely dysmyelinated optic nerves, we turned to the
Plp1 mutant rumpshaker mouse (Schneider et al, 1992) that
exhibits no demyelination. The level of hypomyelination in
P40 rumpshaker mice was similar to that of age-matched
Plp1-transgenic mice. However, CD169þ cells appeared to
be slightly more frequent in rumpshaker (Fig 6A). Only a
small number of CtB foci, indicating local impairment of
retrograde axonal transport (Fig 6B), were present in rump-
shaker and in contrast to Plp1-transgenic mice at age P120, these
foci occurred in similar numbers in both retinal and chiasmal
portions. 2010 EMBO Molecular Medicine 45
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Figure 5. Impaired retrograde axonal transport is associated with active
inflammatory demyelination.
A. Following injection of CtB into the rostral colliculus, the mean signal
intensity in the retinal ganglion cells (RGC) and the area of retina
occupied by labelled cells was determined in WT and transgenic
littermates aged P40 and P120. At P40, there is no significant
difference between transgenic and WT. However, the signal intensity
is significantly lower in the P120 transgenic group, when there is
active, inflammatory demyelination. As the axon counts in the optic
nerves of the two genotypes are also similar the data suggest that the
reduced signal is due to impaired transport rather than axonal loss.
B. Quantification of CtB foci in retinal or chiasmal portions of the P40 or
P120 nerve. At P40, only a few foci are observed and they tend to be
more prevalent in the retinal half of the nerve. However, the
difference between retinal and chiasmal halves is not significant. At
P120, sites of transport stasis are located predominantly in the distal
portion of the nerve.
C. Longitudinal sections of nerve (retinal end left) from a Plp1-trans-
genic mouse aged P120 immunostained for CD45 and showing CtB
positive foci. The sections show the gradient in macrophages and CtB
between the two ends of the optic nerve. Lipofucsin is present in
these nerves, particularly in the chronically demyelinated region, and
is indistinguishable from CtB in these images.
D. Single z step through an SMI32-labelled (red) axon in which FITC–CtB
(green) appears punctuate, suggesting that it may associate with
endosomes and multivesicular bodies. Bar: D¼ 10mm.
E, F. Electronmicrographs of horseradish peroxidase (HRP)-conjugated
CtB, labelled with TMB, in axons in the optic tract of a P120 mouse.
TMB appears as electron dense ‘spikes’. The axons remain patent.
Axons in these images remain myelinated, however in (F), the inner
tongue (asterisk) of the oligodendrocyte is swollen. Arrowheads
indicate axonal organelles. Bar: E,F¼ 1mm.
G, H, I. Eighteen hours after TRITC–CtB (red) and FITC–CtB (green) were
simultaneously injected into the eye and the rostral colliculus,
respectively, confocal microscopy showed that many axonal
swellings contained both tracers. This suggests that the swellings are
associated with defects in both retrograde and anterograde axonal
transport, and also indicates that the associated axon remains intact.
Bar: I¼ 5mm.
46DISCUSSION
Axonal loss is widely accepted as the main determinant of
neurological disability in MS (De Stefano et al, 1998). Axonal
degeneration correlates with inflammatory demyelination in MS
(Ferguson et al, 1997; Trapp et al, 1998), in EAE (Papadopoulos
et al, 2006) and in aged mice in which demyelination is induced
with cuprizone (Irvine & Blakemore, 2006). Whether axonal
injury persists in MS patients once inflammation has resolved
has been debated (Frischer et al, 2009; Trapp et al, 1998). To
determine the relationship between axonal changes and myelin-
related pathology we studied two different models of myelin
disease. The Plp1-transgenic mouse optic nerve shows a
temporo-spatially separated active demyelination with robust
microglial/macrophage activation and chronic hypomyelina-
tion (due to dys- and demyelination) with low-grade inflamma- 2010 EMBO Molecular Medicinetion. The C3H/101 rumpshaker optic nerve exhibits mild
dysmyelination associated with modest cellular activation.
Sites of axonal transport stasis were most prevalent at regions of
active demyelination and inflammation, suggesting that the
presence of inflammatory cells and/or damaged myelin are key
factors.
Rostral to caudal progression of demyelination
The rostral to caudal progression of demyelination in the
Plp1-transgenic mouse mirrors that of developmental myelina-
tion which commences at the optic nerve head approximately
7 days before it does so at the chiasm (Foran & Peterson,
1992). However, it seems unlikely that the small age
difference between retinal and chiasmal oligodendrocytes
explains the pattern of demyelination, which progresses
over weeks in the Plp1-transgenic mouse. One possibility is
that remyelination occurs concurrently with demyelination in
the chiasmal portion of the nerve, but is less efficient in the
retinal portion, manifesting as an apparent gradient of
demyelination.EMBO Mol Med 2, 42–50 www.embomolmed.org
Report
Julia M. Edgar et al.
Figure 6. Relatively few sites of axonal transport stasis are associated
with diffuse, low level inflammation.
A. Longitudinal sections of optic nerve (retinal end left) from the
dysmyelinating rumpshaker mouse aged P40, immunostained for CD45
and CD169 (sialoadhesin). There is no gradient in the distribution of
microglia/macrophages along the optic nerve and activated, sialoadhesin
positive cells are present in low numbers compared to the P120
Plp1-transgenic nerve.
B. Eighteen hours after injection of CtB into the rostral colliculus of
P40 rumpshaker mouse, a relatively small number of CtB positive foci
are present at similar densities in retinal and chiasmal portions of the
nerve.Surprisingly, axonal diameter frequency distributions at the
chiasmal portion of the P120 nerve were not altered compared to
WT. In the retinal portion of the nerve, where complete
demyelination occurred earlier, a greater proportion of axons
were less than 0.6mm in diameter in the Plp-transgenic mouse
compared to the WT (average 34.0% vs. 17.2%, respectively);
however the overall frequency distributions were not signifi-
cantly different. Whereas peripheral nervous system (PNS)
axons and large diameter spinal cord axons are profoundly
influenced by myelination (De Waegh et al, 1992; Tanaka et al,
2009), the subtle differences we observed may be due to the fact
that the size of small diameter optic nerve axons is only
minimally increased by myelination (Kirkpatrick et al, 2001;
Perge et al, 2009).
Sites of transport impairment and swelling do not necessarily
represent axonal transection
Somemarkers of axonal damage, such as focal accumulations of
APP, represent sites of axonal transport stasis but may not
necessarily indicate that the associated axon is transected
(Ferguson et al, 1997). Thus, the damage may be reversible. For
example, in EAE models, transient accumulations of APP have
been correlated with iNOS expression by perivascular macro-
phages (Aboul-Enein et al, 2006) or with co-transfer of antibodies
to neurofascin (Mathey et al, 2007). In these models, the extent
of APP immunoreactivity correlates with clinical symptoms and
subsides during remission, providing indirect evidence that the
affected axons do not degenerate. Here, we took advantage ofwww.embomolmed.org EMBO Mol Med 2, 42–50the anatomy of the optic pathway to show directly, using
simultaneous injection of CtB into the eye and the colliculus that
spheroids belong to intact axons in the demyelinating Plp1-
transgenic mouse.
Similarly, in a mouse model of Alzheimer’s disease, axons
remain continuous along their entire length despite containing
large focal swellings, indicative of a partial block of axonal
transport (Adalbert et al, 2008). Thus, it appears that axonal
transport has an in-built overcapacity, such that most axons can
survive limited transport defects for some time.
Effectors of axonal transport stasis
Sites of transport impairment were noted in the chiasmal
and optic tract portions of the visual pathway at P120,
which at this age represent sites of active, inflammatory
demyelination. Spheroids were noted in both myelinated
internodes and in demyelinated axonal segments. In contrast,
focal sites of transport stasis were much rarer in completely
demyelinated regions where axons appeared structurally intact
and were able, in the case of some axons, to conduct electrical
impulses.
Activated microglia/macrophages probably contribute to
axonal transport stasis at sites of active demyelination. For
example, microglia/macrophage ‘activation’ has been asso-
ciated with low levels of acute axonal injury in pre-demyelinat-
ing lesions in rats receiving focal injection of lipopolysaccharide
(Marik et al, 2007), and inflammatory factors (e.g. nitric oxide
and tumour-necrosis factor (TNF-a)) produced by this popula-
tion, can possibly contribute directly to the dysregulation of
molecular motors (De Vos et al, 2000; Stagi et al, 2006).
Alternatively, these effects could be indirect, for example
triggered by oligodendrocytes that appear physically stressed in
an inflammatory milieu (see Fig 2 Butt et al, (2004)). In this
context, we note that axonal transport stasis can precede
microglial activation and can occur in the absence of
demyelination when axons are ensheathed by dysfunctional
oligodendrocytes, such as in the myelinated Plp1 and Cnp1
knockoutmice (Edgar et al, 2004, 2009; Lappe-Siefke et al, 2003).
Thus, transport impairment in the Plp-transgenic mouse (which
was sometimes observed within myelinated internodes) most
likely indicates that axons are ensheathed by dysfunctional
oligodendrocytes (Edgar & Nave, 2009; Nave & Trapp, 2008).
Good evidence for a functional link between demyelination,
inflammation and axonal changes is provided by a comparison
with shiverer mice, which lack compact myelin in the optic
nerve. Indeed, shiverer mice show no signs of axonal loss/
swelling, unless confronted additionally with the lack of PLP/
DM20 from mutant oligodendrocytes (see Fig 1E (Griffiths et al,
1998)). This confirms that shiverer axons are in principle at risk
for a similar axonal breakdown, but that it requires a ‘second hit’
on top of the lack of myelin. This could be either inflammation
or deficiency of a critical oligodendroglial molecule. Taking
these data together, we propose a model in which both
neuroinflammation and oligodendrocyte dysfunction provide
the highest risk for axonal loss, with demyelination surprisingly
improving the chance of axon survival, at least in the short
term. 2010 EMBO Molecular Medicine 47
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The paper explained
PROBLEM:
Axonal loss is widely accepted as the major cause of permanent
neurological disability in multiple sclerosis (MS), an
inflammatory demyelinating disorder of the central nervous
system. However, the relationship between demyelination,
inflammation and axonal damage in neuroinflammatory
disorders is not yet fully understood.
RESULT:
Using a mouse model of the leukodystrophy, Pelizaeus-
Merzbacher disease, we show that fast transport within optic
nerve axons is focally impaired at sites of damage, where active,
inflammatory demyelination takes place and also at sites where
axons remain ensheathed by mutant oligodendrocytes. Most
interestingly, where demyelination is complete, axons appear
preserved.
IMPACT:
Our results challenge the field to re-think themechanisms of glial
support to axons as they suggest that, at least in the short-term,
neuroinflammation and associated changes aremore deleterious
for axonal health than overt demyelination per se.
48MATERIALS AND METHODS
Mice
The mice used in this study (line #72) carry a cassette harbouring
three copies of a Plp1 genomic transgene (Readhead et al, 1994).
These were backcrossed for more than six generations to the C57BL/
6N (Charles River) background. WT and homozygous mice were
examined at P20, P30, P40, P60 and P120. Only males were used for
quantitative analysis, except for the electrophysiological studies, when
only females were used. See Supporting Information for genotyping
methods. For axonal transport assays (see below), homozygous
transgenic mice were compared to age and sex-matched littermates.
For all other analyses, comparisons were between age and sex-
matched littermates or closely related individuals from the same in-
bred colony.
Rumpshaker (rsh/y) and WT (þ/y) male offspring were also
examined. These were distinguished on the basis of the neurological
phenotype of rumpshaker. All animal studies were approved by the
Ethical Committee of the University of Glasgow and licensed by the UK
Home Office.
Tissue collection and preparation
For electron microscopy, tissues were prepared as described previously
(Griffiths et al, 1981). For immunohistochemistry, frozen tissue
sections were used. Details of the fixatives employed can be found
in Supporting Information.
Antibodies and immunohistochemistry
Antibodies to CD3 (1:100), CD45 (1:600), CD169 (sialoadhesin; 1:100),
B-cells (CD45R/B220; 1:100) and MBP (1:500) were obtained
from Serotec Ltd (Oxford, UK) SMI-32, which recognizes non-
phosphorylated neurofilaments (1:1000) was obtained from Stern-
berger Monoclonals, Inc. (Lutherville, MD). Secondary antibodies were
conjugated with FITC or Texas Red (Cambridge Biosciences). In all
cases (except for B cells) sections were permeabilized with methanol
(20 8C), blocked in 10% goat serum in PBS and incubated 2010 EMBO Molecular Medicineovernight in primary antibody in blocking solution. Secondary
antibodies in blocking solution were applied for 1 h at room
temperature (RT). For the B-cell marker, frozen sections were blocked
and the primary antibody was applied for 1 h at RT. Sections were then
fixed in 4% paraformaldehyde and the secondary antibody applied,
as above.
Digital images
Fluorescence images were taken using an Olympus IX70 microscope,
QIcam Fast digital camera (QImaging Surrey, BC, Canada) and Image-
Pro Plus 6 software (Media Cybernetics, Silver Spring, MD). Images
were processed using Adobe Photoshop. No significant electronic
manipulations were made except to images of longitudinal optic nerve
sections in which tissue debris around the nerve was digitally
removed.
Collicular injections for retrograde transport
To study retrograde axonal transport, WT and Plp1-transgenic
homozygous littermates at P40 and P120, and WT and rumpshaker
littermates at P40, were used. Fluorescein-conjugated CtB subunit
was injected into the right rostral colliculus and its accumulation in
the retina was measured 18h later (Edgar et al, 2004). The total area
occupied by fluorescent signal and the mean density of the signal
were determined using Image-Pro Plus 6 software; data are expressed
as area of fluorescence per mm2 of retina and average mean density
(intensity) of signal.
Intraocular injections for anterograde transport
Some mice were simultaneously injected with FITC–CtB and with 1ml
of 1% TRITC–CtB in physiological saline (Invitrogen Ltd., Paisley, UK)
into the left eye.
TMB labelling and visualization of CtB–HRP by
electronmicroscopy
Twenty-four hours after injection of peroxidase-conjugated CtB
(0.5% CtB/1% peroxidase in sterile PBS; Sigma–Aldrich CompanyEMBO Mol Med 2, 42–50 www.embomolmed.org
Report
Julia M. Edgar et al.Ltd.) into the colliculus of P120 homozygous #72 mice, the animals
were perfused with 1% paraformaldehyde/1% glutaraldehyde/0.1M
PB. Nerves were treated with 0.07% solution of the chromogen
TMB and stabilized with 0.7% 3,3/-diaminobenzidine (DAB) tetra-
hydrochloride/0.33% Cobalt chloride as described by van der Want
et al, (1997). Resin embedded tissue was mounted on blank Araldite
stubbs and 70nm section cut and stained with Reynold’s lead citrate
for EM viewing.
Axonal morphometry and quantification of axonal changes
Axon diameter, density and the myelination status were assessed from
electron micrographs (initial magnification 6700) of randomly
selected fields at the chiasmal end of optic nerve from P20, P40,
P60 and P120 mice. EM negatives were scanned for analysis using
Image-Pro Plus 6 software. Optic nerve areas were measured from
light micrographs. Axon densities and nerve area measurements were
used to derive total numbers. Axon diameter frequency distributions
and the percentage of myelinated axons were also determined. The
myelin volume (Mv) and the axonal volume (Av) were determined by a
point counting method (Williams, 1977). Myelination status was also
ascertained for the retinal end of the optic nerve and the optic tract
from Plp-transgenic mice.
Cell counts
Cell counts were made in the retinal and chiasmal portions of
the optic nerve and in the optic tract. Ten micrometer thick
transverse sections, 90mm apart, were immunostained for CD45,
counterstained with DAPI then photographed at 40 magnification.
At least six sections per region were quantified. The densities of
nucleated CD45þ cells were counted within an area of interest using
Image-Pro Plus 6 software (Al-Saktawi et al, 2003). Optic nerve and
tract transverse areas were measured and the average number of cells
per 10mm thick section was calculated.
Quantification of CtB in retinal and chiasmal portions of
the optic nerve
Longitudinal sections (10mm thick) of the optic nerve from animals
injected with CtB were imaged using a confocal microscope (Leica SP2
AOBS, Leica Microsystems Semiconductor GmbH,Wetzlar, Germany) at
63 magnification. Images were taken through the entire depth of
the tissue, in retinal and chiasmal portions, at 0.5mm steps. The
image stack was flattened and the numbers of CtBþ foci, greater
than 10mm2 were counted within an AOI, using Image-Pro Plus 6
software. Foci<10mm2 could be observed in WT nerves and
therefore were excluded from analysis. At least nine images per
nerve were taken from each animal. Lipofucsin granules, which were
visible in both red and green channels, were excluded from the
analysis.
Electrophysiology
WT and homozygous Plp1-transgenic female mice were killed by
cervical dislocation. The optic nerves were dissected and placed in an
interface perfusion chamber (Medical Systems Corp., Greenvale, NY),
maintained at 378C and superfused with artificial cerebrospinal
fluid (aCSF; see Supporting Information) and aerated by
humidified gas mixture of 95% O2/5% CO2. The CAP was recordedwww.embomolmed.org EMBO Mol Med 2, 42–50following supramaximal stimulation, as described previously (Allen
et al, 2006).
Statistical analyses
A two-sample Kolmogorov–Smirnov test was used to compare
axonal diameter frequency distributions. Calculations were made using
Microsoft Office Excel and significance was assessed by reference to
published tables (Siegal & Castellan, 1988). All other statistical
analyses were made using GraphPad Prism 5 (GraphPad Software,
Inc., San Diego, CA). Comparisons between the morphometry of WTand
homozygous mice were made using a grouped t-test; comparisons
along the length of the optic pathway used ANOVA. The comparisons
between CtB transport in pairs of WT and transgenic littermates were
performed with a paired t-test, as were comparisons between CtB foci
at retinal and chiasmal portions of the optic nerve. Data are expressed
as Mean SEM (N was at least 3) and significance in bar charts
indicated as <0.05 (), <0.01 () and <0.001 ().Authors contributions
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